aniline has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beaulieu, PL; Bolger, G; Duan, J; Duplessis, M; Gagnon, A; Garneau, M; Kukolj, G; Stammers, T | 1 |
1 other study(ies) available for aniline and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Aza follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 1: Mitigating the genotoxic liability of an aniline metabolite.
Topics: Acrylates; Aniline Compounds; Animals; Antiviral Agents; Dogs; Enzyme Inhibitors; Haplorhini; Hepacivirus; Hepatitis C; Humans; Indoles; Rats; Viral Nonstructural Proteins | 2015 |